急性冠状动脉综合征的进展：弥合诊断与治疗的差距
Advances in Acute Coronary Syndromes: Bridging Gaps in Diagnosis and Treatment.
作者信息
Andò Giuseppe, Micari Antonio, Costa Francesco
机构信息
Department of Clinical and Experimental Medicine, University of Messina, Azienda Ospedaliera Universitaria Policlinico "Gaetano Martino", 98124 Messina, Italy.
Department of Biomedical and Dental Sciences and of Morphological and Functional Images, University of Messina, Azienda Ospedaliera Universitaria Policlinico "Gaetano Martino", 98124 Messina, Italy.
出版信息
J Clin Med. 2024 Oct 9;13(19):6003. doi: 10.3390/jcm13196003.
Abstract
Acute coronary syndromes (ACS) have long posed a formidable challenge to cardiovascular care, despite significant advancements in both understanding and treatment over the last few decades [...].
摘要
尽管在过去几十年里，我们对急性冠状动脉综合征（ACS）的认识和治疗都取得了重大进展，但它长期以来一直是心血管护理领域面临的一项艰巨挑战。
相似文献
1
Advances in Acute Coronary Syndromes: Bridging Gaps in Diagnosis and Treatment.
J Clin Med. 2024 Oct 9;13(19):6003. doi: 10.3390/jcm13196003.
2
Capturing the pathophysiology of acute coronary syndromes with circulating biomarkers.
Rev Cardiovasc Med. 2010;11 Suppl 2:S3-12. doi: 10.3909/ricm11S2S0005.
3
Use of novel antiplatelet agents in acute coronary syndromes.
Curr Atheroscler Rep. 2015 Mar;17(3):483. doi: 10.1007/s11883-014-0483-4.
4
Management of acute coronary syndromes in Mexico: gaps and opportunities to improve outcomes.
Am J Cardiovasc Drugs. 2009;9(3):143-8. doi: 10.1007/BF03256571.
5
Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes.
Curr Drug Targets. 2011 Nov;12(12):1831-5. doi: 10.2174/138945011797635876.
6
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units Registry.
J Cardiovasc Med (Hagerstown). 2017 Aug;18(8):580-589. doi: 10.2459/JCM.0000000000000533.
7
A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS).
Eur Heart J. 2002 Aug;23(15):1190-201. doi: 10.1053/euhj.2002.3193.
8
Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry.
Eur Heart J Cardiovasc Imaging. 2018 May 1;19(5):524-531. doi: 10.1093/ehjci/jex102.
9
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation. 2007 May 15;115(19):2549-69. doi: 10.1161/CIRCULATIONAHA.107.182615.
10
From Mars to Venus: Gender Differences in the Management and Outcomes of Acute Coronary Syndromes.
Curr Pharm Des. 2016;22(25):3790-801. doi: 10.2174/1381612822666160328113831.
引用本文的文献
1
Integrated risk factors for premature acute coronary syndrome: residual cholesterol, RDW, and BMI.
Front Cardiovasc Med. 2025 Jun 26;12:1574620. doi: 10.3389/fcvm.2025.1574620. eCollection 2025.
本文引用的文献
1
Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US Sample.
J Clin Med. 2024 May 11;13(10):2844. doi: 10.3390/jcm13102844.
2
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome.
J Clin Med. 2024 Mar 25;13(7):1885. doi: 10.3390/jcm13071885.
3
Dual Antiplatelet Therapy with Parenteral P2Y Inhibitors: Rationale, Evidence, and Future Directions.
J Cardiovasc Dev Dis. 2023 Apr 9;10(4):163. doi: 10.3390/jcdd10040163.
4
The Impact of Emergency Department Arrival Time on Door-to-Balloon Time in Patients with ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention.
J Clin Med. 2023 Mar 20;12(6):2392. doi: 10.3390/jcm12062392.
5
GP IIb/IIIa Receptor Inhibitors in Mechanically Ventilated Patients with Cardiogenic Shock due to Myocardial Infarction in the Era of Potent P2Y12 Receptor Antagonists.
J Clin Med. 2022 Dec 14;11(24):7426. doi: 10.3390/jcm11247426.
6
P2Y Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis.
JACC Cardiovasc Interv. 2022 Nov 28;15(22):2239-2249. doi: 10.1016/j.jcin.2022.08.009. Epub 2022 Oct 26.
7
Incidence, Predictive Factors and Long-Term Clinical Impact of Left Ventricular Remodeling According to the Completeness of Revascularization in Patients with ST-Elevation Myocardial Infarction and Multivessel Disease.
J Clin Med. 2022 Oct 23;11(21):6252. doi: 10.3390/jcm11216252.
8
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study.
EuroIntervention. 2023 Feb 6;18(13):e1108-e1119. doi: 10.4244/EIJ-D-22-00454.
9
Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials.
Int J Cardiol. 2020 Mar 1;302:95-102. doi: 10.1016/j.ijcard.2019.12.054. Epub 2019 Dec 28.
10
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome.
J Am Coll Cardiol. 2019 Feb 26;73(7):758-774. doi: 10.1016/j.jacc.2018.12.023.
Zotero 插件